| Tretinoin | Approved Investigational Nutraceutical | BCL7A | 605 |
downregulated | Tretinoin results in decreased expression of BCL7A mRNA | 12q24.31 | |
| Tretinoin | Approved Investigational Nutraceutical | BCLAF1 | 9774 |
downregulated | Tretinoin results in decreased expression of BCLAF1 mRNA | 6q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BCO2 | 83875 |
upregulated | Tretinoin results in increased expression of BCO2 mRNA | 11q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BCOR | 54880 |
upregulated | Tretinoin results in increased expression of BCOR mRNA | Xp11.4 | |
| Tretinoin | Approved Investigational Nutraceutical | BCORL1 | 63035 |
downregulated | Tretinoin results in decreased expression of BCORL1 mRNA | Xq26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BCRP2 | 400892 |
downregulated | Tretinoin results in decreased expression of BCRP2 mRNA | 22q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | BCS1L | 617 |
downregulated | Tretinoin results in decreased expression of BCS1L mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | BDKRB1 | 623 |
upregulated | Tretinoin results in increased expression of BDKRB1 mRNA | 14q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BDKRB2 | 624 |
upregulated | Tretinoin results in increased expression of BDKRB2 mRNA | 14q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BDNF | 627 |
upregulated | Tretinoin results in increased expression of BDNF mRNA | 11p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BEGAIN | 57596 |
downregulated | Tretinoin results in decreased expression of BEGAIN mRNA | 14q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BEND4 | 389206 |
downregulated | Tretinoin results in decreased expression of BEND4 mRNA | 4p13 | |
| Tretinoin | Approved Investigational Nutraceutical | BEND7 | 222389 |
upregulated | Tretinoin results in increased expression of BEND7 mRNA | 10p13 | |
| Tretinoin | Approved Investigational Nutraceutical | BET1 | 10282 |
downregulated | Tretinoin results in decreased expression of BET1 mRNA | 7q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BEX1 | 55859 |
downregulated | Tretinoin results in decreased expression of BEX1 mRNA | Xq22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BFSP1 | 631 |
downregulated | Tretinoin results in decreased expression of BFSP1 mRNA | 20p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BHLHB9 | 80823 |
downregulated | Tretinoin results in decreased expression of BHLHB9 mRNA | Xq22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BHLHE40 | 8553 |
upregulated | Tretinoin results in increased expression of BHLHE40 mRNA | 3p26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BHMT | 635 |
downregulated | Tretinoin results in decreased expression of BHMT mRNA | 5q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BICD1 | 636 |
downregulated | Tretinoin results in decreased expression of BICD1 mRNA | 12p11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | BID | 637 |
downregulated | Tretinoin results in decreased expression of BID mRNA | 22q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | BIN1 | 274 |
upregulated | Tretinoin results in increased expression of BIN1 mRNA | 2q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BIRC2 | 329 |
upregulated | Tretinoin results in increased expression of BIRC2 mRNA | 11q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BIRC3 | 330 |
downregulated | Tretinoin results in decreased expression of BIRC3 mRNA | 11q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BIRC3 | 330 |
upregulated | Tretinoin results in increased expression of BIRC3 mRNA | 11q22.2 | |